Autres langues Old API Wind-down Ltd.

Actions

ARLZQ

CA03852X1006

Produits pharmaceutiques

Temps Différé OTC Markets Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-

08/05/18	Transcript : Aralez Pharmaceuticals Inc., Q1 2018 Earnings Call, May 08, 2018
13/03/18	Transcript : Aralez Pharmaceuticals Inc., Q4 2017 Earnings Call, Mar 13, 2018

Autres langues

30/05/19	Old API Wind-Down Ltd. Announces Management Changes
06/02/19	Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd
18/01/19	Aralez Pharmaceuticals Inc. Announces Management Changes
31/12/18	Nuvo Pharmaceuticals Inc. completed the acquisition of Aralez Pharmaceuticals Canada Inc. from Aralez Pharmaceuticals Inc..
20/08/18	Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from NASDAQ Composite Index
14/08/18	Aralez Pharmaceuticals Inc. Announces the Resignation of Seth A. Rudnick, Neal F. Fowler and Rob Harris as Directors
10/08/18	Nuvo Pharmaceuticals Inc. signed a letter of intent to acquire Aralez Pharmaceuticals Canada Inc. from Aralez Pharmaceuticals Inc. for $62.5 million.
26/07/18	Aralez Pharmaceuticals Inc. Announces Resignation of James Tursi as Chief Medical Officer, Effective from August 2, 2018
29/06/18	Aralez Pharmaceuticals Inc. Enters into an Amendment to that Certain Second Amended and Restated Facility Agreement with Deerfield Partners, L.P
08/05/18	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
21/03/18	Aralez Pharmaceuticals Inc. Announces Resignation of Mark Glickman as Chief Commercial Officer, Effective on March 30, 2018
14/03/18	Aralez Pharmaceuticals Inc. Appoints Michael Kaseta as Chief Financial Officer
13/03/18	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year 2018
15/12/17	Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from NASDAQ Biotechnology Index
30/11/17	Aralez Pharmaceuticals Inc. Announces Executive Changes
09/11/17	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Revises Earnings Guidance for the Year Ending December 31, 2017 and provides Preliminary Guidance for Full Year Ending December 31, 2018
18/09/17	Aralez Pharmaceuticals Inc.(NasdaqGS:ARLZ) dropped from S&P Global BMI Index
09/08/17	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Revises Earnings Guidance for the Full Year 2017
07/06/17	Aralez Pharmaceuticals Inc. Announces National Commercial Launch of Zontivity in US
07/06/17	Aralez Pharmaceuticals Inc. Announces Resignation of Jason M. Aryeh as Board Member
09/05/17	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Updates Earnings Guidance for the Year Ending December 31, 2017
05/04/17	Aralez Pharmaceuticals to Reduce US Sales Force by 32%
20/03/17	Aralez Mulls Acquisitions
13/03/17	Aralez Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2017; Reports Impairment Charges for the Fourth Quarter of 2016
02/02/17	Aralez Pharmaceuticals Inc. Unveils New Office in Ireland